The Harrison's team has posted an update/summary of a new controlled clinical trial looking at the potential therapeutic benefit of Lopanavir-Ritonavir in the management of COVID-19 infection.
The complete update can be read here
New Harrison's Online COVID-19 Update
New Harrison's Online Update on COVID-19